Kits Eyecare (KITS) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Jul, 2026Executive summary
Achieved record Q4 2024 revenue of $44.8 million, up 42% year-over-year, and full-year revenue of $159.3 million, up 32% from the prior year.
Delivered ninth consecutive quarter of positive adjusted EBITDA, with Q4 adjusted EBITDA at $2.9 million (6.5% margin), up 237% year-over-year, and full-year adjusted EBITDA at $6.4 million, up 182% year-over-year.
Q4 net income was $2.7 million, reversing a net loss in Q4 2023, with EPS of $0.09; full-year net income per share was $0.10.
Customer loyalty remains strong, with 63% of Q4 revenue from existing customers, 79,000 new customers added in Q4, and active customers up 9% year-over-year to 913,000.
Milestone of 1 million glasses shipped since inception.
Financial highlights
Q4 gross profit was $16.3 million, up 47% year-over-year, with gross margin expanding to 36.3%; full-year gross profit was $53.7 million (33.7% margin).
Q4 glasses revenue grew 60% year-over-year to $6.5 million; full-year glasses revenue reached $21.8 million, up 46%.
Fulfillment costs as a percentage of revenue declined to 10.6% in Q4 and 11.1% for the year; G&A expenses were 5.8% of revenue in Q4.
Marketing expenses as a percentage of revenue were 14.6% in Q4 and 13.7% for the year, with improved marketing ROI and new customer revenue up over 50% year-over-year in Q4.
Cash and cash equivalents at year-end totaled $19.3 million, up from $16.0 million a year earlier; cash flow from operations for 2024 was $13.0 million.
Outlook and guidance
Q1 2025 revenue projected between $46 million and $48 million, with adjusted EBITDA margin targeted at 4%-6%.
Annual revenue run rate based on Q4 performance is $179.3 million, indicating continued strong growth.
Expectation for a 10th consecutive quarter of over 30% organic revenue growth.
No anticipated increase in CapEx as a percentage of revenue for 2025; focus remains on operational efficiency and margin expansion.
Management highlights ongoing investment in fulfillment, product innovation, and digital offerings to support future growth.
Latest events from Kits Eyecare
- Q2 revenue up 26% year-over-year to $37.9M, with record profitability and margin gains.KITS
Q2 20248 Jul 2026 - Rapid growth, high customer retention, and online expansion drive long-term value.KITS
Planet MicroCap Las Vegas 202618 Jun 2026 - Record Q1 revenue and profitability driven by 61% glasses growth and strong recurring sales.KITS
Q1 20266 May 2026 - Record revenue and profitability driven by premium glasses, repeat sales, and AI innovation.KITS
Q4 202517 Apr 2026 - All director nominees and the auditor were reappointed, with results to be published on SEDAR+.KITS
AGM 20254 Mar 2026 - Record Q3 2025 revenue and profit driven by Canadian growth and high-margin products.KITS
Q3 20253 Mar 2026 - Automation, data, and influencer-driven marketing fuel strong growth and recurring revenue.KITS
Planet MicroCap Showcase: VANCOUVER 20243 Feb 2026 - Online optical disruptor achieves 30% growth, 65% repeat sales, and targets CAD 500M revenue.KITS
RBC Capital Markets Consumer & Retail Day 20241 Feb 2026 - Raised Q3 guidance above CAD 41M as recurring revenue and automation drive rapid, profitable growth.KITS
2024 Annual Gateway Conference22 Jan 2026